Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?

Literature DB >> 23388618

In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?

Abstract

Cyclin-dependent kinases (CDKs) are regulated by both cyclin abundance and cyclin localization. Increased cyclin expression in cancer was first observed two decades ago, and its role in pathogenesis has been investigated in great depth. This Opinion article focuses on the spatial deregulation of cyclin expression and its potential link to oncogenesis. It describes the contexts in which particular cyclins have been reported to be mislocalized in neoplasia, reviews the mechanisms underlying the dynamic subcellular localization of CDK-cyclin complexes in normal cells, and discusses how these controls can be disrupted in cancer. It also outlines the mechanisms by which cyclin mislocalization might disrupt cell cycle control and interfere with faithful chromosome segregation. Finally, it discusses the extent to which cyclin mislocalization might facilitate tumorigenesis in human cancer.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 2013 PMID： 23388618 DOI： 10.1038/nrc3468

Source DB: PubMed Journal: Nat Rev Cancer ISSN： 1474-175X Impact factor: 60.716

106 in total

1. Inhibition of cyclin-dependent kinase 1 induces cytokinesis without chromosome segregation in an ECT2 and MgcRacGAP-dependent manner.

Authors: Fumihiko Niiya; Xiaozhen Xie; Kyung S Lee; Hiroki Inoue; Toru Miki
Journal: J Biol Chem Date: 2005-08-23 Impact factor: 5.157

2. C-terminal sequences direct cyclin D1-CRM1 binding.

Authors: Sharon Benzeno; J Alan Diehl
Journal: J Biol Chem Date: 2004-10-28 Impact factor: 5.157

3. HURP is a Ran-importin beta-regulated protein that stabilizes kinetochore microtubules in the vicinity of chromosomes.

Authors: Herman H W Silljé; Susanna Nagel; Roman Körner; Erich A Nigg
Journal: Curr Biol Date: 2006-04-18 Impact factor: 10.834

4. Chromatid cohesion defects may underlie chromosome instability in human colorectal cancers.

Authors: Thomas D Barber; Kirk McManus; Karen W Y Yuen; Marcelo Reis; Giovanni Parmigiani; Dong Shen; Irene Barrett; Yasaman Nouhi; Forrest Spencer; Sanford Markowitz; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christoph Lengauer; Philip Hieter
Journal: Proc Natl Acad Sci U S A Date: 2008-02-25 Impact factor: 11.205

5. Quantitative proteomics reveals the basis for the biochemical specificity of the cell-cycle machinery.

Authors: Felicia Walton Pagliuca; Mark O Collins; Agata Lichawska; Philip Zegerman; Jyoti S Choudhary; Jonathon Pines
Journal: Mol Cell Date: 2011-08-05 Impact factor: 17.970

Review 6. Identification of substrates for cyclin dependent kinases.

Authors: Alessia Errico; Krupa Deshmukh; Yoshimi Tanaka; Andrei Pozniakovsky; Tim Hunt
Journal: Adv Enzyme Regul Date: 2010-01-04

7. Identification of a substrate-targeting domain in cyclin E necessary for phosphorylation of the retinoblastoma protein.

Authors: B L Kelly; K G Wolfe; J M Roberts
Journal: Proc Natl Acad Sci U S A Date: 1998-03-03 Impact factor: 11.205

8. Cyclin: a protein specified by maternal mRNA in sea urchin eggs that is destroyed at each cleavage division.

Authors: T Evans; E T Rosenthal; J Youngblom; D Distel; T Hunt
Journal: Cell Date: 1983-06 Impact factor: 41.582

9. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Authors: D E Quelle; R A Ashmun; S A Shurtleff; J Y Kato; D Bar-Sagi; M F Roussel; C J Sherr
Journal: Genes Dev Date: 1993-08 Impact factor: 11.361

10. Cyclin E, a potential prognostic marker for breast cancer.

Authors: K Keyomarsi; N O'Leary; G Molnar; E Lees; H J Fingert; A B Pardee
Journal: Cancer Res Date: 1994-01-15 Impact factor: 12.701

22 in total

Review 1. Low-Molecular-Weight Cyclin E in Human Cancer: Cellular Consequences and Opportunities for Targeted Therapies.

Authors: Joseph A Caruso; Mylinh T Duong; Jason P W Carey; Kelly K Hunt; Khandan Keyomarsi
Journal: Cancer Res Date: 2018-09-07 Impact factor: 12.701

2. Cyclin E Associates with the Lipogenic Enzyme ATP-Citrate Lyase to Enable Malignant Growth of Breast Cancer Cells.

Authors: Kimberly S Lucenay; Iman Doostan; Cansu Karakas; Tuyen Bui; Zhiyong Ding; Gordon B Mills; Kelly K Hunt; Khandan Keyomarsi
Journal: Cancer Res Date: 2016-02-29 Impact factor: 12.701

Review 3. Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors: Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal: Semin Cancer Biol Date: 2015-04-17 Impact factor: 15.707

4. Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer.

Authors: Kelly K Hunt; Khandan Keyomarsi; Cansu Karakas; Min Jin Ha; Anna Biernacka; Min Yi; Aysegul A Sahin; Opoku Adjapong; Gabriel N Hortobagyi; Melissa Bondy; Patricia Thompson; Kwok Leung Cheung; Ian O Ellis; Sarah Bacus; W Fraser Symmans; Kim-Anh Do
Journal: Clin Cancer Res Date: 2016-11-23 Impact factor: 12.531

5. TPX2 overexpression in medullary thyroid carcinoma mediates TT cell proliferation.

Authors: Xiaolin Yang; Geling Liu; Hongzhen Xiao; Fang Yu; Xiuxiu Xiang; Yifang Lu; Weijuan Li; Xiuling Liu; Sha Li; Yanping Shi
Journal: Pathol Oncol Res Date: 2014-02-01 Impact factor: 3.201

6. The 19q12 bladder cancer GWAS signal: association with cyclin E function and aggressive disease.

Authors: Yi-Ping Fu; Indu Kohaar; Lee E Moore; Petra Lenz; Jonine D Figueroa; Wei Tang; Patricia Porter-Gill; Nilanjan Chatterjee; Alexandra Scott-Johnson; Montserrat Garcia-Closas; Brian Muchmore; Dalsu Baris; Ashley Paquin; Kris Ylaya; Molly Schwenn; Andrea B Apolo; Margaret R Karagas; McAnthony Tarway; Alison Johnson; Adam Mumy; Alan Schned; Liliana Guedez; Michael A Jones; Masatoshi Kida; G M Monawar Hosain; Nuria Malats; Manolis Kogevinas; Adonina Tardon; Consol Serra; Alfredo Carrato; Reina Garcia-Closas; Josep Lloreta; Xifeng Wu; Mark Purdue; Gerald L Andriole; Robert L Grubb; Amanda Black; Maria T Landi; Neil E Caporaso; Paolo Vineis; Afshan Siddiq; H Bas Bueno-de-Mesquita; Dimitrios Trichopoulos; Börje Ljungberg; Gianluca Severi; Elisabete Weiderpass; Vittorio Krogh; Miren Dorronsoro; Ruth C Travis; Anne Tjønneland; Paul Brennan; Jenny Chang-Claude; Elio Riboli; Jennifer Prescott; Constance Chen; Immaculata De Vivo; Edward Govannucci; David Hunter; Peter Kraft; Sara Lindstrom; Susan M Gapstur; Eric J Jacobs; W Ryan Diver; Demetrius Albanes; Stephanie J Weinstein; Jarmo Virtamo; Charles Kooperberg; Chancellor Hohensee; Rebecca J Rodabough; Victoria K Cortessis; David V Conti; Manuela Gago-Dominguez; Mariana C Stern; Malcolm C Pike; David Van Den Berg; Jian-Min Yuan; Christopher A Haiman; Olivier Cussenot; Geraldine Cancel-Tassin; Morgan Roupret; Eva Comperat; Stefano Porru; Angela Carta; Sofia Pavanello; Cecilia Arici; Giuseppe Mastrangelo; H Barton Grossman; Zhaoming Wang; Xiang Deng; Charles C Chung; Amy Hutchinson; Laurie Burdette; William Wheeler; Joseph Fraumeni; Stephen J Chanock; Stephen M Hewitt; Debra T Silverman; Nathaniel Rothman; Ludmila Prokunina-Olsson
Journal: Cancer Res Date: 2014-10-15 Impact factor: 12.701